ARTICLE | Translation in Brief

Mining marine metabolites

Sirenas, BMS use AI to discover small molecule microbiome metabolites

March 22, 2018 12:21 AM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) is tapping Sirenas LLC’s AI platform Atlantis to discover microbiome metabolites for immuno-oncology.

Atlantis applies data mining, computational modeling and machine learning technology to screen microbiome-derived metabolites against cellular and biochemical disease models, which then become the basis for synthetic chemistry campaigns to yield immuno-modulatory candidates...